Wenmin Zhou
Impact in
-
- Cancer Genomics and Diagnostics
-
- Conducting polymers and applications
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Jianye Zhang (12 shared papers)Qiaoru Guo (7 shared papers)Yuqi Yang (2 shared papers)Zhe‐Sheng Chen (2 shared papers)Hui Wang (1 shared paper)Chang Zou (1 shared paper)Yanyan Yan (5 shared papers)Jingquan Li (2 shared papers)
- Journals
- Frontiers in Pharmacology (3 papers)World Journal of Traditional Chinese Medicine (1 paper)Frontiers in Oncology (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wenmin Zhou
14 papers receiving 479 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 72
- Polymers and Plastics 60
- Biomedical Engineering 167
- Oncology 93
- Cognitive Neuroscience 49
Countries citing papers authored by Wenmin Zhou
This map shows the geographic impact of Wenmin Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenmin Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenmin Zhou more than expected).
Fields of papers citing papers by Wenmin Zhou
This network shows the impact of papers produced by Wenmin Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenmin Zhou. The network helps show where Wenmin Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Wenmin Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 121 | |
| 2 | 2020 | 93 | |
| 3 | 2021 | 85 | |
| 4 | 2020 | 49 | |
| 5 | 2020 | 38 | |
| 6 | 2020 | 25 | |
| 7 | 2021 | 24 | |
| 8 | 2021 | 24 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 2 | |
| 14 | 2022 | 1 | |
| 15 | 2022 | 0 |
About Wenmin Zhou
Wenmin Zhou is a scholar working on Oncology, Molecular Biology, Organic Chemistry, Pharmacology and Biomedical Engineering, having authored 15 papers that have together received 488 indexed citations. Recurring topics across this work include Synthesis and biological activity (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cytokine Signaling Pathways and Interactions (1 paper), Natural Compounds in Disease Treatment (1 paper), Nanoplatforms for cancer theranostics (1 paper), Advanced Materials and Mechanics (1 paper), Advanced Control Systems Optimization (1 paper) and Advanced Algorithms and Applications (1 paper). The work is most often cited by research in Cancer Research (72 citations), Polymers and Plastics (60 citations), Biomedical Engineering (167 citations), Oncology (93 citations) and Cognitive Neuroscience (49 citations). Wenmin Zhou has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jianye Zhang, Qiaoru Guo, Yuqi Yang, Zhe‐Sheng Chen, Hui Wang, Chang Zou, Yanyan Yan, Jingquan Li, Yanchao Mao and Shengxin Xiang. Their work appears in journals such as Frontiers in Pharmacology, World Journal of Traditional Chinese Medicine, Frontiers in Oncology, Frontiers in Cell and Developmental Biology and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.